Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by <i>Staphylococcus</i> spp. and Vancomycin-Resistant Enterococci

One approach to combat the increasing incidence of multidrug-resistant (MDR) bacterial pathogens involves repurposing existing compounds with known safety and development pathways as new antibacterial classes with potentially novel mechanisms of action. Here, triclabendazole (TCBZ), a drug originall...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Hongfei Pi, Abiodun D. Ogunniyi, Bhumi Savaliya, Hang Thi Nguyen, Stephen W. Page, Ernest Lacey, Henrietta Venter, Darren J. Trott
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2021-08-01
Σειρά:	Microorganisms
Θέματα:	multidrug resistance triclabendazole polymyxin B bacterial pathogens bioluminescence sepsis
Διαθέσιμο Online:	https://www.mdpi.com/2076-2607/9/8/1697
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!